|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Trophoblastic Neoplasms | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Gestational Trophoblastic Neoplasms | |||||
| Hydatidiform Mole | |||||
| Neoplasms | |||||
| 3 | More general conditions related to this trial | ||||
| Neoplasms by Histologic Type | |||||
| Neoplasms, Germ Cell and Embryonal | |||||
| Pregnancy Complications | |||||
| Pregnancy Complications, Neoplastic | |||||
| 4 | Interventions listed in this trial | ||||
| chemotherapy agents | |||||
| suction curettage | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Chorionic Gonadotropin | |||||
| 6 | More general drug interventions related to this trial | ||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Reproductive Control Agents | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| National Taiwan University Hospital | |||||
| National Science Council, Taiwan | |||||